As miR-200c has so far been shown to target HO-1 and is associated with HO-1 decreased expression in other tissues and cancer types [74,75], we did not expect that it could be a mediator of HO-1 upregulation or action in bladder cancer. This evidence concerns the gene HMOX1 and urinary bladder carcinoma.